Bharat Biotech to conduct Phase 3 trials for COVAXIN
2020-10-24 5
The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials. Watch the video for more details.
